About GT Biopharma Inc. Common Stock
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
Market Cap
$0.01B
Employees
1
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.gtbiopharma.comPhone
(800) 304-9888
Headquarters
315 MONTGOMERY STREET
SAN FRANCISCO, CA 94104
CIK
0000109657